A pragmatic, randomized clinical trial to evaluate the effect of a heart failure (HF) risk assessment and prevention strategy incorporating HF clinical risk scores (WATCH-DM) with cardiac biomarker (NT-proBNP) paired with a clinical decision support tool to implement an intensive prevention strategy among patients with high risk focused on implementation of evidence-based HF preventive therapies.
Primary care providers will be randomized to receive notifications via the electronic health record if any patients with diabetes have high heart failure risk based on a combination of clinical risk scores(WATCH-DM), and biomarkers (NT-proBNP). Providers will be provided recommendation to initiate evidence based therapies (SGLT2 inhibitors, GLP1 agonists, non-steroidal MRA) , obtain expert e-consultation, or refer the patient to a cardiometabolic risk management program.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
300
Providers randomized to the intensive prevention strategy will receive notification about patients with diabetes who have high heart failure risk and recommendations for medical management, e-consultation, or referral to a cardiometabolic risk management program.
University of Texas Southwestern Medical Center
Dallas, Texas, United States
RECRUITINGIncident Heart Failure or All-cause death
Incident Heart Failure (based on electronic health record International Classification of Diseases codes) or all-cause death. This will be assessed via retrospective chart review.
Time frame: 2-year follow-up
Prescription Rates of SGLT2i
Counts of SGLT2 inhibitor prescriptions filled
Time frame: 6-months from electronic health record alert.
Prescription Rate of Finerenone
Counts of Finerenone prescriptions
Time frame: 6-months from electronic health record alert.
Prescription Rate of GLP1
Counts of GLP1 prescription
Time frame: 6-months from electronic health record alert.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.